反应源疗法治疗原发性高血压临床观察

Reactive Origin Therapy in the Treatment of Essential Hypertension

  • 摘要: 应用反应源疗法治疗原发性高血压,按随机双盲和安慰剂对照的方法,在高血压患者的反应源处皮下注射丹莲注射液,观察106例,有效率为96.2%,显效率84.9%。停止治疗后1~15个月随访患86人,其中33人血压回升为高血压,53人血压正常(占61.6%)。对照组的年龄、性别、病情、病程和治疗前血压平均值与治疗组差异均无显著性。治疗组收缩压和舒张压的平圴值显著下降,对照组均无效,方差分析,差异有高度显著性(P<O.001)。2个对照组间差异无显著性(P>0.05)。

     

    Abstract: We use"reactive origin therapy" of traditional medicine to treat 106 cases ofessential hypertension.The study was randomized,double blind and with placebo as controls.No significant differences in age,sex,symptoms,duration of hypertension and pretreatment BP between the the treated and control groups have been found.After"reactive origin therapy",the total effective rate was 96.2%,remarkable effective rate was 84.9%,86 cases were followed for 1~15 months after the stopping of therapy.Sustained normal blood pressure was found in 50 among them.The long term successful rate was 61.6%.

     

/

返回文章
返回